Patient Self-sampling of HPV to Screen for Cervical Cancer
Validation and Feasibility of Patient Self-sampling of HPV for Cervical Cancer Screening
2 other identifiers
interventional
222
1 country
1
Brief Summary
The purpose of this study is to validate a patient self-sampling vaginal collection kit and laboratory testing for the detection of HPV (human papillomavirus) infection. Researchers will compare the laboratory results of self-collected vaginal swab samples to usual healthcare provider-collected cervical swab samples to determine the laboratory HPV testing accuracy of the self-collection swab.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2022
CompletedFirst Posted
Study publicly available on registry
October 31, 2022
CompletedStudy Start
First participant enrolled
November 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 4, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 4, 2024
CompletedResults Posted
Study results publicly available
September 19, 2025
CompletedJanuary 6, 2026
October 1, 2024
1.6 years
October 26, 2022
August 6, 2025
December 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concordance of Patient-collected and Clinician-collected Samples to Detect HPV Infection
Patient-collected vaginal swab HPV results compared with gold standard of clinician-collected cervical swab) to accurately detect HPV infection
Baseline (sample was collected up to 21 days form the date of registration)
Secondary Outcomes (1)
Patient-reported Acceptability of Using the Evalyn Brush
Baseline (sample was collected up to 21 days form the date of registration)
Study Arms (1)
Self-collected vaginal swab samples
EXPERIMENTALSubjects will self-collect a vaginal swab (Evalyn brush) and complete a scheduled standard of care clinician-collected cervical swab
Interventions
Patient self-sampling swab kit to collect a vaginal sample for HPV testing
Speculum exam and collection of a cervical specimen using standard endocervical brush and spatula placed into ThinPrep medium for HPV testing (Evalyn brush)
Eligibility Criteria
You may qualify if:
- Appointment at Mayo Clinic Rochester in Gynecology Colposcopy Clinic or ICS (integrated community specialty) Colposcopy Clinic (will always include a speculum exam).
- Appointment at Mayo Clinic Rochester in Gynecology Clinic for indication that will already include a speculum exam (e.g., cervical cancer screening or IUD insertion).
You may not qualify if:
- Excluded if self-reported as currently menstruating, pregnant, or within 3 months following pregnancy.
- Excluded if no cervix (history of total hysterectomy).
- Excluded if moderate to heavy vaginal bleeding on the day of the visit.
- Excluded if reason for visit in Gynecology Clinic is abnormal vaginal discharge.
- Exclude patients who are on Gynecology Colposcopy Clinic for LEEP (loop electrosurgical excision procedure).
- Exclude if any use of over-the-counter or prescription vaginal cream for vaginal infection or prescription vaginal estrogen cream for at least two days before using the Evalyn Brush.
- (Vaginal contraceptives, condoms and water-based lubricants can be used as normal.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic Minnesota
Rochester, Minnesota, 55905, United States
Related Links
Results Point of Contact
- Title
- Dr. Kathy MacLaughlin
- Organization
- Mayo Clinic
Study Officials
- PRINCIPAL INVESTIGATOR
Kathy MacLaughlin, MD
Mayo Clinic
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 26, 2022
First Posted
October 31, 2022
Study Start
November 16, 2022
Primary Completion
June 4, 2024
Study Completion
June 4, 2024
Last Updated
January 6, 2026
Results First Posted
September 19, 2025
Record last verified: 2024-10
Data Sharing
- IPD Sharing
- Will not share